tirzepatide by eli lilly (LLY) Gets Nod to Launch Weight-Loss Drug Mounjaro in Hong Kong Lilly's tirzepatide slashes risk of

"The lipolytic fragment of human growth hormone: biological activity and mechanism of action." Growth Hormone & IGF Research, vol

Its darkly ironic that, despite the increased awareness and use of GLP-1 drugs in our society, weight stigma is still so prevalent

Why ARA-290 Is Different from Erythropoietin Erythropoietin: Increases red blood cell production Raises hematocrit Increases thrombosis risk at high levels ARA-290: Does not affect red blood cells Does not raise hematocrit Does not increase clotting risk This distinction makes ARA-290 suitable for chronic use in inflammatory and neurologic conditions , where EPO would be unsafe

V., & Jacobsen, P

GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration. Biomed Res Int 2015:648108

aHR, 0.66